MONDAY, Oct. 14, 2024 (HealthDay News) — A simple tweak in available vial sizes of the breakthrough Alzheimer’s drug Leqembi could save Medicare hundreds of millions of dollars each year, a new analysis claims. About 6% of Leqembi (lecanemab) is discarded because patients are frequently prescribed doses lower than theContinue Reading

TUESDAY, Oct. 1, 2024 (HealthDay News) — Following the historic destruction of Hurricane Helene, many Americans must now return to their mangled homes and begin the heartbreaking task of clean-up. After making landfall in Florida near Tallahassee as a ferocious Cat 4 storm on Thursday, Helene caused record-breaking storm surgesContinue Reading

MONDAY, Sept. 30, 2024 (HealthDay News) — More than 14 million seniors a year take a tumble, and those falls can be life-changing.  “The relationship between falls and dementia appears to be a two-way street,” said Molly Jarman, senior author of a new study showing that cognitive decline may increaseContinue Reading

THURSDAY, Sept. 26, 2024 (HealthDay News) — Brain damage that veterans suffered from flying shrapnel has provided a major clue that could lead to better treatment for post-traumatic stress disorder (PTSD), a new study says. Veterans who suffered shrapnel damage connected to their amygdala, the fear center of the brain,Continue Reading

WEDNESDAY, Sept. 25, 2024 (HealthDay News) — During a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO Lars Fruergaard Jørgensen faced tough questions over the company’s high prices for its blockbuster drugs Ozempic and Wegovy. While testifying before the Senate Committee on Health, Education, Labor and Pensions,Continue Reading